Zu den Inhalten springen

Comprehensive Cancer Center Freiburg - CCCF

Center for Multiple Myeloma

Dear patients!

Multiple Myeloma is the second most common blood cancer disease in adults. The risk of developing the disease increases with increasing age. The median age of onset is 70 years. Multiple myeloma significantly impairs quality of life through bone pain, organ dysfunction, and chronic fatigue. Treatment therefore requires interdisciplinary collaboration. Patients today have the chance to live well with the disease.

Outpatient Department and Consultation Hours

 

 

Central outpatient hotline at the Interdisciplinary Tumor Center ITZ: Telephone: +49 (0)761 270-35555
Map
Registration for appointments at the Center for Multiple Myeloma: Telephone: +49 (0)761 270-71580
Consultation hour for multiple myeloma / plasmacytoma:
Prof. Dr. Monika Engelhardt: Telephone: +49 (0)761 270-32460

Interdisciplinary Tumor Center
Hugstetter Str. 53
79106 Freiburg

Events

The Center for Multiple Myeloma regularly holds informational events for patients: Find out more. Moreover, the Department of Medicine I regularly holds events for doctors, nurses, patients, family members, and the interested public. Click here for a calendar of upcoming events and further training courses (in German). 

Self-Help

Support groups for people with the same disease are an opportunity to exchange information and experiences independently without professional guidance as well as to give and receive emotional support. Find out more (in German)
Members of support groups are experts in matters that affect them personally and often possess a high degree of “lay competence.” Your regional support group (in German)

 

Diagnosis, Treatment, & Trials

We strive to provide a directed diagnosis and therapy, which we discuss in our multiple myeloma board with internists, radiologists, orthopedists, radiotherapists, pathologists, biologists, and other specialists. The standard methods for treating multiple myeloma are chemotherapy, genetic therapy, and radiation therapy. For patients of up to around 70 years, chemotherapy is usually followed by a stem cell transplantation (in German). Our treatment endeavors to achieve a good balance between response to therapy and maintenance of quality of life. Very many of our patients experience a complete remission that lasts for years. A tightly knit regimen of follow-up examinations after therapy is absolutely essential.

Trials

Around one-third of our patients participate in trials on the development of new therapies and maintenance of quality of life.

Find out more (in German)

 

Team

Prof. Dr. Monika Engelhardt
Director
Telephone: +49 (0)761 270-32460
monika.engelhardt@uniklinik-freiburg.de

curriculum vitae (in German)

Dr. Michael Rassner
Coordinator
Telephone: +49 (0)761 270-36000
michael.rassner@uniklinik-freiburg.de

Events

Saturday, 26 November 2022

9th Patients' and Relatives' Day

Responsible: Prof. Dr. Monika Engelhardt

Place: Max Weber School Freiburg

Talks at the CCCF Cancer Information Day on 6 March 2021

Interdisciplinary Tumor Board Projects as Exemplified by the Myeloma Board | Prof. Dr. Monika Engelhardt, Department of Medicine I (in German)

Sports Study on Patients with Multiple Myeloma | Mandy-Deborah Möller, Department of Medicine I (in German)

Clinical Pathway
Multiple Myeloma Conference

 

 

 

When: Monday, 3:30 p.m.
Where: Interdisciplinary Tumor Center ITZ, R.00.153

Registration: Telephone: +49 (0)761 270-77722
Intranet: TOS
tumorboardzentrale@uniklinik-freiburg.de
Registration deadline: Monday, 10 a.m.
2 continuing education credits from the Baden-Württemberg State Medical Association

More information

Certificate from the German Cancer Society

Download